Therefore, the inhibition of CHK1 and CHK2 becomes of interest either as an adjuvant for chemotherapy treatments or in looking for compounds that have a cytotoxic effect on cancer cells, inhibiting their survival pathways. The gene discussed is CHEK2; the disease is cancer.